A study led by Professor Chng Wee Joo from the Cancer Science Institute of Singapore at the National University of Singapore has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells. Credit: Image courtesy of National University of Singapore
A small molecule drug combined with chemotherapy may deliver a synergistic benefit for colorectal cancer patients has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells.
PRIMA-1met is a compound that has been shown in previous studies to activate mutant p53, a tumour suppressor gene, and promotes death of cancer cells...
Read More
Recent Comments